Clinical Trial Biorepository & Archiving Solutions Market: Strategies for Optimizing Sample Storage

The global market for clinical trial biorepository and archiving solutions was valued at $4 billion in 2023 and is projected to grow at an annual rate of 8.17% from 2024 to 2030. This growth is primarily driven by pharmaceutical companies outsourcing their R&D activities to enhance their core competencies. Additionally, the economic benefits of outsourcing, such as reduced costs compared to investing in cold storage equipment, are also contributing to the market's expansion. However, keeping up with evolving storage and transportation technologies, global regulatory requirements, and current bio-storage trends can be both time-consuming and costly.

Contract Research Organizations (CROs) are experiencing significant revenue growth due to increasing R&D expenditures and the growing focus of pharmaceutical companies on developing novel drugs at reduced costs. Biopharmaceutical companies are increasingly outsourcing their clinical trials to CROs to accelerate product development and reduce costs. This trend is likely to continue as CROs become more capable of handling complex research, thereby reducing the additional efforts required by biopharmaceutical companies to monitor complex clinical trial processes.

 

Gather more insights about the market drivers, restrains and growth of the Clinical Trial Biorepository & Archiving Solutions Market

 

Regional Insights:

 

North America Clinical Trial Biorepository & Archiving Solutions Market Trends

North America held the largest market share in 2023, accounting for 47.99%. This significant share is driven by the surge in clinical trials and the expansion efforts of multiple market players in the region. Additionally, the availability of advanced technology, as exemplified by Thermo Fisher Scientific's expansion of central laboratory operations in the U.S. in June 2024, is further propelling the region's market growth.

U.S.

The U.S. holds the largest share of the North American clinical trial biorepository and archiving solutions market. This growth is fueled by two key factors: a surge in clinical trials and a booming market for companies offering related services. Looking at the numbers, a significant portion of global clinical trials take place in the U.S. Data from Atlassciences LA, current as of July 2022, shows that out of 422,201 registered studies on ClinicalTrials.gov, a staggering 32% were conducted within the U.S. This high volume of clinical activity translates to a strong demand for biorepository and archiving solutions.

Furthermore, the U.S. boasts a robust presence of Contract Research Organizations (CROs) like Quintiles, Covance, Inc., and PAREXEL International Corporation. These CROs offer a comprehensive range of services, including biorepository and archiving solutions, which further contributes to the market's growth in the U.S.

 

Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market Trends

The clinical trial biorepository and archiving solutions market in the Asia Pacific region is poised for significant growth, with an expected compound annual growth rate (CAGR) of 14.22% during the forecast period. This robust growth is fueled by the ongoing expansion and advancement of clinical research activities within the region.
Several factors contribute to this market's dynamism. The relatively low cost per patient in Asia Pacific countries and the availability of a diverse patient pool that is easily accessible for recruitment create a favorable environment for clinical trials. These factors, coupled with the increasing focus on personalized medicine and the growing need for long-term storage and analysis of biological samples, are driving the demand for efficient biorepository and archiving solutions.

 

China

China's clinical trial biorepository and archiving solutions market led the global industry in 2023. This dominance is attributed to the nation's vast and diverse patient pool, coupled with a rapidly expanding pharmaceutical sector. Additionally, positive policy shifts, including the implementation of Good Supply Practices for pharmaceutical products, are poised to further stimulate market growth within China.

India

India's clinical trial biorepository and archiving solutions market is poised for significant growth in the coming years. A key driver behind this expansion is the surge in clinical trials within the country, particularly driven by the rising prevalence of chronic diseases like cardiovascular diseases, kidney diseases, and diabetes. This increasing demand for effective treatment options necessitates robust biorepository and archiving solutions to store and analyze biological samples, thereby accelerating drug discovery and development.

 

Europe Clinical Trial Biorepository & Archiving Solutions Market Trends

The European clinical trial biorepository & archiving solutions market is poised for significant growth due to technological advancements, a surge in clinical trials, and the presence of key players offering innovative solutions. This region, particularly Germany, is leading the way with its technological advancements, high-quality clinical resources, and increasing demand for clinical trials fueled by numerous CROs.

Germany

Germany's clinical trial biorepository and archiving solutions market is poised for significant growth in 2023. This growth is primarily driven by advancements in technology and the availability of high-quality clinical resources within the country. Additionally, the increasing demand for clinical trials in Germany and the presence of several prominent Contract Research Organizations (CROs) are further fueling the market's expansion. These factors collectively contribute to the growing demand for effective biorepository and archiving solutions, ultimately driving market growth over the forecast period.

 

UK

The UK market is also projected to expand due to high demand for clinical trials and the presence of key players like Bristol Biomedical Research Center and Biocentre. These factors are driving the overall growth of the European clinical trial biorepository & archiving solutions market.

 

Browse through Grand View Research's Category Medical Devices Industry Research Reports.

• The global cervical disc prosthesis market size was estimated at USD 350.88 million in 2024 and is projected to grow at a CAGR of 12.4% from 2025 to 2030.

• The global smart medical devices market size was estimated at USD 90.55 billion in 2024 and is expected to grow at a CAGR of 12.84% from 2025 to 2030.

 

Key Companies & Market Share Insights

Several key players are strategically bolstering their market presence by offering clinical trial biorepository & archiving solutions for innovative pharmaceutical vaccines and drugs. These strategies encompass agreements, new product launches, partnerships, mergers and acquisitions/joint ventures, expansions, and other initiatives aimed at increasing market penetration, revenue, and competitive advantage, ultimately driving market growth.

 

Key Clinical Trial Biorepository & Archiving Solutions Companies

 

The following are the leading companies in the clinical trial biorepository & archiving solutions market. These companies collectively hold the largest market share and dictate industry trends.

• Medpace
• American Type Culture Collection (ATCC)
• Cell&Co BioServices (Cryoport)
• Brooks Life Sciences (Azenta, Inc.)
• Patheon (Thermo Fisher Scientific, Inc.)
• Precision Medicine Group, LLC.
• Labcorp Drug Development
• Q2 Solutions
• LabConnect
• Charles River Laboratories

Order a free sample PDF of the Clinical Trial Biorepository & Archiving Solutions Market Intelligence Study, published by Grand View Research.